New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For GE;DELL;GSK;AZN;BEN;AAPL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
May 22, 2015
16:41 EDTAAPLStocks end week little changed despite weaker than expected domestic data
Subscribe for More Information
16:24 EDTAZNAmgen to end participation in co-development and commercialization of brodalumab
Amgen (AMGN) announced the company has commenced termination of its participation in the co-development and commercialization of brodalumab with AstraZeneca (AZN). Brodalumab, an investigational IL-17 inhibitor, is in development for patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis. The decision was based on events of suicidal ideation and behavior in the brodalumab program, which Amgen believes likely would necessitate restrictive labeling. After Amgen transitions the program to AstraZeneca, future decisions on the clinical development and submission of marketing applications for brodalumab will be at the sole discretion of AstraZeneca for all territories, except for certain Asian territories, including Japan, where Kyowa Hakko Kirin has rights to brodalumab. Amgen has decided to focus its efforts and resources on other key molecules that address unmet medical needs and deliver value to patients and shareholders. The Company continues to make progress against its strategic and financial commitments and does not expect any meaningful impact from this decision on its ability to meet them.
16:00 EDTAAPLOptions Update; May 22, 2015
Subscribe for More Information
12:21 EDTAAPLApple to focus on quality instead of new additions in OS upgrade, 9to5Mac says
Subscribe for More Information
11:00 EDTAAPLIntel may be launching next-gen Skylake chips in August, Apple Insider says
Subscribe for More Information
10:52 EDTGSK, AZNJPMorgan says Actavis shares cheap compared to peers
Subscribe for More Information
10:39 EDTAAPLData firm: Apple Watch orders haven't grown since initial surge, Quartz says
Subscribe for More Information
10:38 EDTAAPLMizuho says buy NXP, Micron, ON Semi
Mizuho Securities initiated coverage of a number of chip makers in a note to investors last night. Among its recommendation in the space, NXP Semiconductors (NXPI), Micron (MU), and ON Semiconductor (ON) were called out with Buy ratings. NXP: NXP Semiconductors dominates the mobile payment market with its NFC products, Mizuho analyst Vijay Rakesh wrote. The company's NFC chips are used in Apple's (AAPL) Apple Pay and NXP has a strong mobile payment ecosystem in China, the analyst explained. NXP Semiconductors is also a leader in providing chips used to enhance credit card security, as its Chip+Pin system has a 75% share of the global market and is in the process of being deployed in the U.S, according to Rakesh. Going forward, NXP's growth should be driven by the automotive products of Freescale, which the company acquired earlier this year, the analyst stated, adding that NXP should derive strong synergies and cash flow from the deal. He set a $140 price target on the stock. MICRON: Sales of flash memory device maker Micron's DRAM products should be boosted by a PC rebound in the second half of this year, according to Rakesh. Additionally, the company's new CFO could make its actions more predictable, pleasing investors, the analyst stated. ON: ON Semiconductor should benefit from its acquisition of Aptina, which gave ON a significant presence in the Advanced Driver Assistance Systems, or ADAS, market, Rakesh believes. ADAS is likely to grow rapidly around the world, driven by mandates, the analyst predicted. A second positive catalyst for ON will be the proliferation of wireless charging, added the analyst, who set a $16 price target on the shares. PRICE ACTION: In early trading, NXP rose nearly 1% to trade nearly $108, Micron gained 2.6% to $27.61, and ON was fractionally higher. Other semiconductor makers initiated with Buy ratings by the firm include Skyworks (SWKS), Synaptics (SYNA), Avago (AVGO) and Cypress Semiconductor (CY).
09:34 EDTAAPLActive equity options trading on open
Active equity options trading on open: AAPL BABA AMZN FB MU BIDU SDRL BAC INTC EXPE CHK FEYE
09:01 EDTAAPLApple wants TV service to have local programming, Re/code reports
Subscribe for More Information
06:56 EDTAAPLTrendforce expects iPhone shipments to reach 230M in 2015, DigiTimes says
Trendforce said Apple's iPhone shipments is expected to reach over 230M in 2015, reports DigiTimes. The 4.7-inch and 5.5-inch versions of the next iPhone will enter mass production in June and will be shipped in Q3. Quarterly shipments is projected to reach 24M units. Reference Link
06:35 EDTAAPLApple developing dual-app mode, 12-inch iPads, multi-user support, 9to5Mac says
Subscribe for More Information
May 21, 2015
17:16 EDTAAPLApple plans 12-inch iPads, split-screen functionality, 9to5Mac says
Subscribe for More Information
16:00 EDTAAPLOptions Update; May 21, 2015
Subscribe for More Information
15:25 EDTAAPLApple to add public transit support to Maps app, 9to5Mac says
Subscribe for More Information
14:14 EDTAAPLMobileye says not currently at work with Apple
Mobileye (MBLY) announced that an article published in InformationWeek on May 20 quoted an industry expert and current director as stating that the company is commencing work with Apple (AAPL) on an autonomous driving project. Mobileye stated: "The company is not currently at work with Apple. Although it is not the company's policy to comment on press reports or other media, the article has caused confusion and concern among market participants. As a result, the company felt it was important to correct the inaccuracy. The company has asked the publication to correct the article on its website."
12:40 EDTAZNHayman's Bass requests review of POZEN patents
Subscribe for More Information
11:21 EDTAAPLApple considers expansion into San Jose, Silicon Valley Business Journal says
Subscribe for More Information
10:58 EDTAZNDeutsche Bank biotech analyst holds an analyst/industry conference call
Subscribe for More Information
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:07 EDTAAPLApple may unveil next iPhones in August, MacRumors reports
Apple may unveil its next iPhones in August and launch them in September, reports MacRumors. According to a research note from KGI Securities Ming-Chi Kuo, Foxconn is expected to secure between 60%-70% of orders to assemble the new iPhones. Reference Link
08:27 EDTGEGeneral Electric announcements positive, says Bernstein
Subscribe for More Information
07:58 EDTAAPLApple iPhone and Watch estimates raised at Morgan Stanley
Morgan Stanley's checks indicate June quarter iPhone demand is tracking ahead of Street expectations and Watch demand has jumped following the launch. The firm raised its June quarter iPhone unit estimate to 50M from 46M, FY15 unit estimate to 240M, and FY16 unit estimate to 249M. Morgan Stanley raised its base case Watch estimate to 36M units from 30M in the first 12 months. As a result, the firm's CY15 EPS estimate is increased 6% to $9.73, roughly in-line with consensus. The firm has an Overweight rating with a $166 price target on Apple shares.
07:51 EDTAAPLIPhone growth fears premature, says Oppenheimer
Oppenheimer expects investors to question whether Apple's growth can continue at recent rates, given the tough comps it is facing. The firm thinks these doubts could pressure the stock, but it expects the company's earnings growth to continue to come in above expectations, driven by iPhone share gains, momentum in China, Apple's ecosystem, new product categories, and shareholder-friendly actions. The firm keeps a $155 price target and Outperform rating on the stock.
07:44 EDTGEWoodward to host conference call
Subscribe for More Information
07:37 EDTAZN, GSKPfizer replaces AbbVie as top global pharma pick at Jefferies
Subscribe for More Information
07:36 EDTGEJoint venture a significant positive for Woodward, says Stifel
Subscribe for More Information
07:13 EDTAAPLApple showing substantial issue with iCloud services, 9to5Mac reports
Subscribe for More Information
06:43 EDTAAPLTSMC to manufacture fingerprint sensors for next iPhone, DigiTimes reports
Subscribe for More Information
06:10 EDTGEStocks with implied volatility below IV index mean; LNKD GE
Subscribe for More Information
05:52 EDTAAPLTesla batteries may surpass $1B in sales faster than iPhone, Economic Times says
Subscribe for More Information
05:48 EDTGEGE willing to sell IP rights in Alstom deal, Financial Times says
Subscribe for More Information
05:41 EDTAAPLUber poaches new legal counsel Sabrina Ross from Apple, Re/code reports
Subscribe for More Information
05:38 EDTAAPLApple Pay may launch in Europe sooner than expected, BGR reports
Subscribe for More Information
May 20, 2015
19:54 EDTAAPLApple streaming music service coming first to Russia, Billboard says
Subscribe for More Information
16:15 EDTGEGE Aviation, Woodward combine fuel systems expertise for new joint venture
Subscribe for More Information
16:14 EDTGEWoodward to repurchase $250M in shares over next 12 months
Subscribe for More Information
16:00 EDTAAPL, GEOptions Update; May 20, 2015
iPath S&P 500 VIX Short-Term Futures up 3c to 19.19. Option volume leaders: AAPL AAL YHOO DAL FB BABA UAL BAC TWTR LUV C TSLA GE MU
11:57 EDTGEGE says going for SIFI de-designation in 2016
11:51 EDTAZNExpress Scripts' Medco to pay $7.9M to resolve kickback allegations
Medco Health Solutions, a wholly-owned subsidiary of the pharmacy benefit manager Express Scripts Holding Company (ESRX), of Missouri, has agreed to pay the government $7.9M to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act, the Justice Department announced. Medco provides pharmacy benefit management services to clients who receive subsidies under the Medicare Retiree Drug Subsidy program. The settlement resolves allegations that Medco solicited remuneration from AstraZeneca, a pharmaceutical manufacturer, in exchange for identifying Nexium as the “sole and exclusive” proton pump inhibitor on certain of Medco’s prescription drug lists known as formularies. The United States alleged that Medco received some or all of the remuneration from AstraZeneca in the form of reduced prices on the following AstraZeneca drugs: Prilosec, Toprol XL and Plendil. The United States contended that this kickback arrangement between Medco and AstraZeneca (AZN) violated the Federal Anti-Kickback statute, and thereby caused the submission of false or fraudulent claims for Nexium to the Retiree Drug Subsidy Program. In January 2015, the United States and AstraZeneca reached a $7.9M settlement to resolve kickback allegations arising out of the same conduct. This civil settlement resolves a lawsuit filed under the qui tam, or whistleblower, provision of the False Claims Act, which allows private citizens with knowledge of false claims to bring civil actions on behalf of the government and to share in any recovery. The lawsuit was filed by former AstraZeneca employees Paul DiMattia and F. Folger Tuggle, whose share of the settlement has not been determined. The settlement with Medco was the result of a coordinated effort among the Civil Division, the U.S. Attorney’s Office of the District of Delaware and HHS-OIG.
11:39 EDTGEGE CEO Immelt confident Alstom deal will get approved
Subscribe for More Information
11:38 EDTGEGE CEO sees having a 'good' business in Oil&Gas
Targets reduction of approximately $1B in cumulative cost.
11:35 EDTGEGE CEO says company is in good shape financially
Subscribe for More Information
11:33 EDTGEGeneral Electric says Aviation will be better than prior view
11:31 EDTGEGE sees about $100B in finance asset sales in 2015 up from $90B
Subscribe for More Information
11:21 EDTGEGE capital portfolio execution ahead of plan
Subscribe for More Information
11:18 EDTGEGE on track for 2015 framework, sees solid organic growth and margin enhancement
Information from slides presentation prepared for 2015 Electrical Products Group Conference.
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
07:46 EDTGSKDeutsche Bank positive on potential Pfizer, GSK merger
Deutsche Bank analyst Gregg Gilbert believes a large foreign deal for Pfizer (PFE) may make sense and says a buyout of GlaxoSmithKline (GSK) could be "materially" accretive to earnings while improving the company's tax situation over time. Gilbert assumes a $60 per share buyout price for GlaxoSmithKline in a research note this morning titled "Introducing 'PfizerKline'". The stock closed yesterday up 2c to $44.68. Gilbert reiterates a Buy rating on Pfizer with a $41 price target. Shares ended yesterday up 23c to $34.21.
07:14 EDTGEElectric Products Group to hold a conference
EPG 2015 is being held in Longboat Key, Florida on May 18-20 with webcasted company presentations to begin on May 20 at 7:30 am; not all company presentations may be webcasted. Webcast Link
06:25 EDTAAPLSamsung could release next Galaxy Note phone as early as July, BI reports
Subscribe for More Information
06:17 EDTGEGeneral Electric looking to sell Australia commercial lending unit, WSJ reports
Subscribe for More Information
06:08 EDTGEStocks with implied volatility below IV index mean; DD GE
Subscribe for More Information
May 19, 2015
18:54 EDTGEGE to lose $350M locomotives deal if Export-Import Bank fails, Reuters says
Subscribe for More Information
18:01 EDTGEAflac names Matthew Owenby as Chief Human Resources Officer
Subscribe for More Information
16:23 EDTAAPLOn The Fly: Top stock stories for Tuesday
Subscribe for More Information
16:01 EDTAAPLOptions Update; May 19, 2015
iPath S&P 500 VIX Short-Term Futures down 27c to 19.17. Option volume leaders: AAPL BAC WMT MSFT FB TWTR MNKD NFLX T PBR
15:05 EDTAZNArdelyx scheduled for end Phase 2 meeting with FDA scheduled in June
Subscribe for More Information
13:52 EDTAAPLPiper Jaffray says shelving television plans won't hurt Apple shares
Following a report by The Wall Street Journal that Apple (AAPL) shelved its television set plans "more than a year ago," Piper Jaffray issued a research note updating its view on the company. WHAT'S NEW: Prior to the market open, The Wall Street Journal released an article stating that, according to people familiar with the matter, Apple has "quietly shelved" its plans to develop a high-definition television set. The company experimented with video calls and 4K resolution as it searched for a justification to enter the TV market, but ultimately decided to instead focus on an online television service and a redesigned Apple TV device. Following the release of that article, Piper Jaffray analyst Gene Munster issued a note reconciling its long-held hope for an Apple television set with the Wall Street Journal's cancellation news. Later in the afternoon, Carl Icahn appeared on CNBC to respond to his recent open letter claiming that Apple was significantly undervalued, partly because of expectations for an Apple television set by 2016. In the CNBC interview, Icahn claimed the Wall Street Journal's article is contradictory, but maintained that the purpose of his letter was to spur additional stock repurchases by Apple. WHAT'S NOTABLE: Piper Jaffray said it believes there will be "no sustained impact" to Apple shares on the news because most analysts did not have definite expectations for a television. The firm believes that Apple will continue to develop its Apple TV set top box and possibly incorporate HomeKit, Siri, and an app store into the next model of the device. However, Piper did reiterate its belief that Apple will somehow move into the living room, citing statements by CEO Tim Cook calling the TV viewing experience "broken." The firm believes Apple is "actively" developing virtual and augmented reality products, though it cautions that a product launch could be five years away, if not more. Piper concluded with a reminder that its television expectations were not built into its model for Apple, and reiterated its Overweight rating and $162 price target. PRICE ACTION: Apple has advanced fractionally during the trading session, rising 0.35% to $130.65 at time of writing.
12:47 EDTAAPLIcahn says will 'definitely be wearing' Apple Watch, but does not have one yet
Subscribe for More Information
12:39 EDTAAPLIcahn says Apple CEO, board doing 'great job'
Subscribe for More Information
12:36 EDTAAPLIcahn says letter had 'one purpose,' getting Apple to buy back more stock
Icahn says "one thing" he disagrees with Apple about is the company's stock repurchase levels. Icahn said if Apple decides not to build a television it does not change his view of the company "one iota." Icahn says he "talks from time to time" with Apple CEO Tim Cook, but he will not discuss what is said in those talks publicly as one of the company's larger shareholders. Carl Icahn is speaking on CNBC.
12:32 EDTAAPLCarl Icahn says 'a bit confused' by WSJ report on Apple television plans
Subscribe for More Information
12:25 EDTAAPLOn The Fly: Top stock stories at midday
Subscribe for More Information
09:37 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:25 EDTGSKGlaxoSmithKline asthma drug overused, risks underappreciated, ProPublica says
Subscribe for More Information
09:25 EDTAAPLJim Cramer tells Apple CEO to acquire Harman
Subscribe for More Information
09:20 EDTAAPLApple estimates raised on iPhone gains at Cleveland Research
Cleveland Research's iPhone feedback remains favorable and raised unit forecasts on improving share gains. The firm is modeling 48M iPhone units for the June quarter, 232M for FY15, and 241M for FY16 vs estimates of 45M, 228M, and 232M respectively. Cleveland rates Apple a Neutral.
08:34 EDTAAPLApple introduces 15-inch MacBook Pro with Force Touch trackpad
Subscribe for More Information
08:04 EDTGEGE announces launch of Digital Wind Farm
Subscribe for More Information
07:12 EDTAAPLAlibaba's Ma confirms talks with Apple over payment system talks, Reuters says
Alibaba (BABA) Executive Chairman Jack Ma confirmed reports that the company is talks with Apple (AAPL) over cooperation for a payment system, Reuters reports. Apple CEO Tim Cook last week told the official news agency of China, Xinhua, that the iPhone maker is in talks with Chinese banks and Alibaba about launching Apple Pay in China. Reference Link
06:55 EDTGSKGenocea could be takeover target after data, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff expects Genocea Biosciences (GNCA) will report positive Phase II GEN-003 post-immunization results late in Q2. GEN-003 is a therapeutic vaccine for genital herpes targeting Herpes Simplex Virus Type 2. Positive GEN-003 data could position Genocea as a potential acquisition target by a larger vaccine player, Tenthoff tells investors today in a research note. Large vaccine makers include Sanofi (SNY), Merck (MRK), GlaxoSmithKline (GSK), Pfizer (PFE) and Novartis (NVS). The analyst reiterates an Overweight rating on Genocea with a $14 price target. Shares of the clinical-stage vaccine developer with a $227M market capitalization closed yesterday up 83c to $10.22.
06:48 EDTAAPLApple shelved plans to produce ultra-HD television, WSJ reports
Apple tried hard to find breakthrough features that would warrant building an ultra-high-definition television set, but after nearly a decade of research, executives did not see a compelling enough reason to enter the highly competitive TV market, according to The Wall Street Journal, citing people familiar with the matter. Reference Link
06:29 EDTAAPLBlackBerry CEO says smartphone business will be profitable again, BI reports
Subscribe for More Information
06:06 EDTAAPLPiper thinks shelving TV won't hurt shares of Apple
Piper Jaffray analyst Gene Munster says Apple's shelving of its plans to make a television is unlikely to have a sustained impact on the stock. After the Wall Street Journal suggested that Apple has scrapped a program to make a television, Munster points out that investor expectations for a TV were low and that Street estimates do not reflect such a product. The analyst still believes Apple will continue to develop the Apple TV as a set top box. He keeps an Overweight rating on Apple with a $162 price target.
06:01 EDTGEStocks with implied volatility below IV index mean; MSFT GE
Subscribe for More Information
05:59 EDTAAPLSources: Apple able to launch iPhone 6s as early as August, BGR says
Subscribe for More Information
May 18, 2015
16:21 EDTAAPLOn The Fly: Top stock stories for Monday
Stocks on Wall Street advanced in Monday trading, sending the Dow Jones Industrial Average and the S&P 500 to new all-time closing highs. The early part of the day saw the market move in a narrow range, but by early afternoon the market punched through its upper range and moved to session highs. The market drifted throughout the afternoon as the news flow was quiet and the trading volume remained light. ECONOMIC EVENTS: In the U.S., the National Association of Home Builders’ confidence index fell 2 points to a reading of 54 in May, missing expectations for a 1 point increase to a reading of 57. COMPANY NEWS: Shares of Apple (AAPL) advanced $1.47, or 1.14%, to $130.24 after noted investor Carl Icahn stated in an open letter to the company's CEO that he thinks other investors, analysts and the news media continue to misunderstand Apple and that its stock is "worth $240 today." Icahn urged Apple CEO Tim Cook to take advantage by launching a "much larger buyback" of the iPhone maker's shares. Separately, FBR Capital analysts Daniel Ives and James Moore wrote this morning in a note to investors that the Street is still underestimating Apple's growth outlook in China. The analysts believe that Apple's China revenue will exceed its revenue from the Americas in fiscal 2017... Endo International (ENDP) slid $4.53, or 5.31%, to $80.82 after the company agreed to pay $8B for privately held Par Pharmaceutical, which will roughly double Endo’s generics revenue and place its generics business among the top five as measured by U.S. sales. MAJOR MOVERS: Among the notable gainers was Ann Inc. (ANN), which surged $7.69, or 19.87%, to $46.40 after agreeing to be acquired by Ascena Retail Group (ASNA) for about $2.15B in cash and stock. Ascena, which agreed to pay $37.34 in cash and 0.68 of a share of its own common stock in exchange for each share of the parent of the Ann Taylor brand, slipped 14c, or 0.99%, to $14.07 after announcing the deal. Also higher was Achillion (ACHN), which rose $1.41, or 14.79%, to $10.98 after the company cancelled its presentation at the UBS Global Healthcare Conference. Conference cancellations often generate speculation as to whether a company is engaged in merger or acquisition talks. Among the noteworthy losers was Eleven Biotherapeutics (EBIO), which dropped $8.29, or 69.26%, to $3.68 after announcing the company’s Phase 3 study of its lead drug candidate, EBI-005, in moderate to severe dry eye disease did not meet either of its two co-primary endpoints. Also lower were shares of Weibo (WB), which fell 87c, or 5.24%, to $15.73 after the shares were downgraded to Hold from Buy at Summit Research. INDEXES: The Dow rose 26.32, or 0.14%, to 18,298.88, the Nasdaq gained 30.15, or 0.6%, to 5,078.44, and the S&P 500 added 6.47, or 0.3%, to 2,129.20.
16:14 EDTGEColfax announces acquisition of Roots blowers & compressors
Colfax Corporation (CFX) announced that it has entered into a binding agreement to acquire the Roots blowers and compressors business unit , also known as Industrial Air & Gas Technologies, from GE (GE) Oil & Gas for a cash consideration of $185M. Roots is a leading supplier of blower and compressor technologies which service a broad range of end markets, including water treatment, chemical production, and power generation. This acquisition will build on Howden's global strength in compressors and blowers and will add important application expertise and product solutions to the portfolio. In 2014, Roots had approximate revenues of $155 million and EBITDA of $22M. In making the announcement, Steve Simms, President and Chief Executive Officer of Colfax, stated, "I am delighted to welcome the Roots team to Colfax. We are excited by the opportunities created by combining the Roots capabilities and application expertise with Howden's global footprint and continuous improvement culture. Like Howden, the Roots business has spent more than 150 years developing market leading products and solutions, and we look forward to continuing to innovate and grow." Mr. Simms continued, "Strengthening our businesses through bolt-on acquisitions is a core part of our strategy, and we continue to see a robust pipeline of opportunities."Closing of the acquisition is expected early in the third quarter following the fulfillment of certain conditions.
16:00 EDTAAPLOptions Update; May 18, 2015
Subscribe for More Information
14:04 EDTAAPLEarnings Watch: Wal-Mart sees Q1 EPS 95c-$1.10, U.S. SSS up 1%-2%
Subscribe for More Information
13:49 EDTAAPLEarnings Watch: Home Depot sees FY15 EPS $5.11-$5.17, revenue growth 3.5%-4.7%
Home Depot (HD), a home improvement retailer, is scheduled to report first quarter results before the market opens on Tuesday, May 19, with a conference call scheduled for 9:00 am ET. EXPECTATIONS: Analysts are looking for earnings per share of $1.15 on revenue of $20.82B, according to First Call. The consensus range for EPS is $1.12-$1.19 on revenue of $20.47B-$21.26B. LAST QUARTER: Home Depot reported fourth quarter adjusted EPS of $1.00 on revenue of $19.16B, beating analysts' consensus estimates for 89c and $18.7B, respectively. The company said same-store sales increased 7.9%, with U.S. SSS up 8.9%. The company forecast fiscal year 2015 EPS of $5.11-$5.17 on revenue growth of 3.5%-4.7%, against estimates at that time for $5.23 and $86.46B, respectively. Home Depot also guided to FY15 SSS growth of 3.3%-4.5% and said it expected FY15 gross margin to be flat, with a tax rate of approximately 37%. Capital expenditures for FY15 were foreseen at $1.6B, with cash flow from business at $9B. In addition to reporting better than expected Q4 earnings, Home Depot also announced an $18B share repurchase program and increased its quarterly dividend by 26% to 59c. NEWS: On its Q4 earnings conference call, Home Depot said it expected moderate GDP growth and housing recovery to drive growth in 2015. The company noted that if foreign currency rates continued as they were in February, sales in 2015 could be negatively impacted by $1B. At March's Raymond James conference, Home Depot backed its guidance for FY15. The company also said it sees FY15 operating margin approximately 60bps to greater than 13%. The company plans to open six new stores in FY15, including five stores in Mexico and one in Canada. The retailer is targeting FY15 share repurchases of $4.5B. On May 5, MacRumors reported that Home Depot may begin phasing out support for Apple Pay (AAPL) at its retail stores. Point72 Asset Management announced that it liquidated its stake during the quarter. STREET RESEARCH: In March, Oppenheimer said it believes that Home Depot has a number of positive catalysts, including solid U.S. consumer spending trends, significant slack in the U.S, housing recovery, improving market sentiment and investors' interest in domestic plays as the dollar strengthens. The firm raised its price target to $133 from $115 and kept an Outperform rating on the stock. On April 26, Barron's said shares of Home Depot could rise towards $124 as the housing market regenerates and demand for renovation grows. BofA/Merrill said the home improvement is one of the more attractive areas within retail and recommended buying Home Depot. During the quarter, Home Depot was initiated with a Hold rating and $108 target at Cantor. PRICE ACTION: Over the last three months, Home Depot shares are up over 1.5%. Ahead of Tuesday's earnings, Home Depot is fractionally higher at $113.77.
12:51 EDTAAPLOn The Fly: Top stock stories at midday
Subscribe for More Information
11:49 EDTAAPLApple readying new features for Apple Watch, 9to5Mac reports
Subscribe for More Information
11:26 EDTAAPLFBR, Icahn both say Apple being underappreciated
Subscribe for More Information
11:08 EDTAAPLIcahn says Apple shares 'worth $240 today,' urges 'much larger' buyback
In an open letter to Apple CEO Tim Cook posted to his Shareholder's Square Table website, investor Carl Icahn stated that he believes Apple shares "are worth $240 today." With Apple’s shares trading for "just $128.77 per share" versus Icahn's valuation of $240 per share, the investor said it is the time for a "much larger buyback" to be launched by the company. Apple’s earnings multiple has stayed "irrationally discounted," according to Icahn, since investors, analysts and the news media continue to misunderstand Apple and "generally fail to value Apple’s net cash separately from its business, fail to adjust earnings to reflect Apple’s real cash tax rate, fail to recognize the growth prospects of Apple entering new categories, and fail to recognize that Apple will maintain pricing and margins."
11:04 EDTAAPLCarl Icahn says Apple shares 'worth $240 today'
Subscribe for More Information
09:36 EDTGE, AAPLActive equity options trading on open
Subscribe for More Information
09:36 EDTAAPLAppeal says Samsung $930M damages to Apple must be adjusted, Bloomberg reports
The U.S. Court of Appeals for the Federal Circuit ruled that Samsung (SSNLF) did infringe Apple’s (AAPL) design patents, but did not violate Apple’s trade dress, meaning the $930M damages award to Apple must be adjusted, reported Bloomberg. Reference Link
09:26 EDTAAPLApple gets mixed ruling from appeals court in Samsung case, Bloomberg reports
Subscribe for More Information
08:28 EDTAAPLApple Watch volume down but mix is up. says UBS
Subscribe for More Information
08:07 EDTGESplunk appoints Snehal Antani as Chief Technology Officer
Subscribe for More Information
07:29 EDTAAPLApple China growth underappreciated by investors, says FBR Capital
Subscribe for More Information
06:56 EDTGEGE, Emerson said to be mulling bids for Aveva, Sunday Times reports
Subscribe for More Information
06:13 EDTAZNAstraZeneca to invest $285M in new biologics manufacturing facility in Sweden
AstraZeneca announced that it plans to invest approximately $285M in a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The new plant will be focused on filling and packaging of protein therapeutics. It is anticipated that the new facility will supply medicines for clinical trial programs of AstraZeneca and MedImmune, the company’s global biologics research and development arm, from the end of 2018, and will deliver finished products for commercial use once fully operational by 2019. Södertälje is currently home to AstraZeneca’s largest global tablets and capsules manufacturing facility and is also a launch platform site for the company, with specialist capabilities on-site that allow large-scale production of new medicines, working closely with the research and development organisation. By locating the new manufacturing plant in Södertälje, the company will combine its expertise in biologics with the well-established culture of operational excellence that exists within the Sweden Operations unit. The planned investment will, subject to relevant approvals by the local authorities, create between 150 and 250 highly skilled new roles at AstraZeneca by 2019. The new manufacturing facility in Sweden will support the progression of drug candidates across the main therapy areas and be aligned with investments being made in the current biologics manufacturing centers, such as the expansion in Frederick, Maryland, announced in November.
06:05 EDTGEStocks with implied volatility below IV index mean; MSFT GE
Stocks with implied volatility below IV index mean; Microsoft (MSFT) 17, General Electric (GE) 15 according to iVolatility.
May 17, 2015
18:04 EDTAAPLApple acquires Coherent Navigation, NYT says
Subscribe for More Information
15:49 EDTAZNAstraZeneca reports Movantik shows 'similar' adverse event rate vs. placebo
Subscribe for More Information
May 15, 2015
18:37 EDTGEGeneral Electric awarded $105M government contract modification
General Electric - Aviation, Cincinnati, Ohio, has been awarded a $105M modification to previously awarded contract FA8650-09-D-2922 to cover the potential award of the Adaptive Engine Technology Development order. This additional research and the resulting data will further mature aircraft engine technologies and decrease risk to achieve a system level preliminary design review and subsequent Adaptive Engine Research Design compatibility review. Work will be performed at Cincinnati, Ohio, and is expected to be complete by Nov. 3, 2016. Funds will be obligated if additional in-scope work is awarded. Air Force Research Laboratory, Wright-Patterson Air Force Base, Ohio, is the contracting activity.
16:01 EDTAAPLOptions Update; May 15, 2015
iPath S&P 500 VIX Short-Term Futures down 20c to 20.06 Option volume leaders: AAPL BAC FB NFLX TWTR BABA CSCO TSLA MU GILD T MSFT AMZN MCD
15:11 EDTGSKGlaxoSmithKline reports 16.12% stake in HTG Molecular
Subscribe for More Information
11:28 EDTAAPLSpotify to roll out streaming service next week, CNBC reports
Subscribe for More Information
11:08 EDTAAPLOmega Advisors gives quarterly update on stakes
NEW STAKES: Targa Resources (TRGP), Targa Resources Partners (NGLS), Humana (HUM), Dow Chemical (DOW), and Twenty-First Century Fox (FOXA). INCREASED STAKES: Kinder Morgan (KMI), Chimera Investment Corporation (CIM), AerCap Holdings (AER), Shire (SHPG), and KKR & Co. (KKR). DECREASED STAKES: eBay (EBAY), Altisource Portfolio Solutions (ASPS), Caesars Entertainment (CZR), Navient (NAVI), and TerraForm Power (TERP). LIQUIDATED STAKES: HCA Holdings (HCA), Gilead (GILD), Cabot Oil & Gas (COG), and Apple (AAPL).
10:23 EDTAAPLQuanta says Apple Watch yield rate no longer an issue, DigiTimes reports
Subscribe for More Information
09:37 EDTAAPLActive equity options trading on open
Active equity options trading on open: AAPL TWTR TSLA NFLX FB
09:31 EDTAZN, GSKAmerican Thoracic Society to hold a conference
ATS 2015 Conference is being held in Denver on May 15-20.
06:03 EDTGEStocks with implied volatility below IV index mean; MSFT GE
Stocks with implied volatility below IV index mean; Microsoft (MSFT) 17, General Electric (GE) 15 according to iVolatility.
May 14, 2015
19:11 EDTAAPLApple job listing hints at map service overhaul
Subscribe for More Information
18:39 EDTAAPLApple, others raise objections to sale of RadioShack customer data, Law360 says
Subscribe for More Information
17:36 EDTAAPLApple responds to rumored HomeKit delay, says first device next month, WSJ says
Subscribe for More Information
17:17 EDTAAPLApple submits patent application to expand 'home button' features
Subscribe for More Information
16:00 EDTAAPLOptions Update; May 14, 2015
Subscribe for More Information
14:04 EDTAAPLApple delays launch of HomeKit to early fall, Fortune reports
Subscribe for More Information
09:34 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:22 EDTAZNLeerink pharma/biotech analysts hold an analyst/industry conference call
Subscribe for More Information
07:34 EDTAAPLApple search volume continues to surge in China, says UBS
Subscribe for More Information
06:29 EDTAAPLApple Music to have deep social integration for artists, 9to5Mac reports
Subscribe for More Information
06:17 EDTAAPLApple plans expansion of key Irish plant, Irish Independent reports
Subscribe for More Information
06:16 EDTAAPLApple and A123 prepare to settle employee-poaching lawsuit, WSJ reports
Subscribe for More Information
05:52 EDTAZNMizuho expects CAR T stocks to be volatile after ASCO abstract
Subscribe for More Information
May 13, 2015
17:24 EDTAZNAstraZeneca to update progress with immuno-oncology pipeline at ASCO
AstraZeneca and MedImmune, the company’s global biologics research and development arm, will demonstrate rapid progress with their combination-focused oncology pipeline at the American Society of Clinical Oncology, or ASCO, Annual Meeting, May 29-June 2. 61 scientific abstracts will be presented at the meeting, reinforcing the significant progress in immuno-oncology through combination therapies and innovative companion diagnostics.
16:06 EDTAAPLOptions Update; May 13, 2015
iPath S&P 500 VIX Short-Term Futures down 38c to 20.67. Option volume leaders: AAPL CSCO NTI FB CSX BABA EIX BAC DD WMB TSLA JCP QCOM DAL
13:15 EDTAAPLInquirer discusses recent Apple for BlackBerry takeover rumors
Subscribe for More Information
11:38 EDTGSKGlaxoSmithKline downgraded to Neutral from Buy at UBS
Subscribe for More Information
11:17 EDTGEGE looks to sell Japan commercial finance operation, WSJ says
General Electric is looking to sell its Japanese commercial finance operations, as the conglomerate looks to slim down assets held in its GE Capital unit, says the Wall Street Journal. The unit, which finances the purchase of equipment is valued at about $5B, added the Wall Street Journal. Reference Link
09:39 EDTAAPL, GEActive equity options trading on open
Subscribe for More Information
07:52 EDTAAPLApple Watch margins will grow to over 50%, says UBS
Subscribe for More Information
07:08 EDTGEOppenheimer to hold a conference
Subscribe for More Information
07:07 EDTGSKGSK, Emergent BioSolutions, Oxford initiate Prime Boost study of Ebola vaccine
A new phase 1 study has begun at the University of Oxford that will investigate the use of a modified vaccinia Ankara, or MVA, Ebola Zaire vaccine candidate, or MVA EBOZ, as a prime-boost to GlaxoSmithKline's (GSK) Chimp Adenovirus type 3, or ChAd3, Ebola vaccine candidate. The study, being conducted by the clinical research group of Professor Adrian Hill of the Jenner Institute, has received regulatory approval to begin from the United Kingdom's Medicines and Healthcare Products Regulatory Agency, or MHRA. The phase 1 study has a planned enrollment of 38 volunteers of which 6 will receive MVA EBOZ only while the other 32 will receive ChAd3-EBO-Z prime followed by MVA EBOZ boost. Emergent BioSolutions (EBS) manufactured the supply of MVA EBOZ to be used in this phase 1 study, which is being conducted in the U.K. with support from the Wellcome Trust and the U.K. Department for International Development.
07:03 EDTAAPLNext iPhone to feature 12 MP camera, be offered in rose gold, AppleInsider says
For its next iPhone 6 model, Apple will offer a new rose gold option, according to KGI Securities analyst Ming-Chi Kuo, who did not make clear whether the luxury model would be made of actual gold or if it will simply resemble the color of the high-end Apple Watch Edition, reported AppleInsider. Kuo also said Apple will upgrade the camera to 12 megapixels and suggested that some "Plus" models may use scratch-resistant sapphire covers, though that is dependent on success in testing, the report added. Reference Link
06:55 EDTAAPLInsiders speculate bidding war to erupt over AOL, Business Insider reports
The consensus speculation from investment bankers, hedge fund traders and people close to AOL (AOL) is that another company will emerge and offer a price for AOL that is higher than $50 per share, reports Business Insider. The potential suitors include Time Warner (TWX), Comcast (CMCSA), Yahoo (YHOO), Alibaba (BABA), Softbank (SFTBF), AT&T (T), Netflix (NFLX) and Apple (AAPL). Reference Link
06:15 EDTGEEU restart probe of GE's planned acquisition of Alstom's power business, WSJ say
Subscribe for More Information
05:55 EDTAAPLTSMC awarded orders for SSD controller chips for Apple, DigiTimes reports
TSMC (TSM) has landed SSD controller chip orders from Apple, reports DigiTimes. According to industry sources, TSMC will utilize a 28nm process to fabricate controller cihps for Apple. Reference Link
May 12, 2015
16:01 EDTAAPLOptions Update; May 12, 2015
Subscribe for More Information
15:50 EDTAAPLSamsung releases next-gen smart watch details to developers, SamMobile says
Subscribe for More Information
13:06 EDTAAPLVivendi says talking to Spotify about streaming, Bloomberg reports
Vivendi (VIVHY) said on its earnings conference call that is having discussions with Spotify regarding a streaming service, Bloomberg reports. Apple's (AAPL) streaming service may affect music sales and margins, Vivendi noted. Shares of Spotify competitor Pandora (P) are up 36c to $18.53 in afternoon trading.
10:45 EDTGEAnalyst says Pall deal may spark more life sciences M&A
Subscribe for More Information
09:51 EDTGEPall Corp. could be precursor to more Life Science deals, says Janney Capital
After The Wall Street Journal said Pall Corp. (PLL) is nearing a possible sale, naming Thermo Fisher (THO) and Danaher (DHR) as potential suitors, Janney Capital said it thinks dealmaking in the Life Sciences space won't stop with Pall, listing Repligen (RGEN), Bio-Techne (TECH) and VWR (VWR) as others in the industry that could see strategic bids emerge. The firm added that it expects that GE (GE), 3M (MMM), and private equity firms would also be involved in bidding in deals in the space.
09:38 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:31 EDTAAPLApple likely to launch TV video service this year, says Pacific Crest
Subscribe for More Information
07:41 EDTAAPLApple CEO says holding talks about Apple Pay with Alibaba, Reuters reports
Subscribe for More Information
06:58 EDTAAPLApple examines new nano material touch panels, ETNews reports
Apple (AAPL) is planning to example nano new material on touch panels, reports ETNews. The company expects the new technology to raise sense of touch and decrease cost. According to unnamed sources, Apple requested AgnW touch-panel samples that is verified for mass-production from LG Display (LPL), Samsung Display (SSNLF), Japan Display and other suppliers. Reference Link
06:02 EDTGSKGSK CEO cites 'poor choices' in rivals' M&A deals, Financial Times reports
Subscribe for More Information
May 11, 2015
17:23 EDTGEGE would consider concessions to secure Alstom deal, Reuters says
Subscribe for More Information
16:47 EDTBENFranklin Resources announces April AUM $894.9B
Franklin Resources reported preliminary month-end assets under management by the company's subsidiaries of $894.9B at April 30, compared to $880.6B at March 31, and $895.4B at April 30, 2014.
16:00 EDTAAPLOptions Update; May 11, 2015
Subscribe for More Information
15:54 EDTGSKGlaxo CEO defends strategy, warns of risks of chasing higher prices, FT says
GlaxoSmithKline (GSK) CEO Andrew Witty defends the company's shift in focus from high-priced prescription drugs to higher volume, but lower priced, products, warning that chasing ever-higher prices risks undermining the industry and may create "its own tension that leads to some kind of change,” reported Financial Times, citing an interview. Witty acknowledges the company's asset swap with Novartis (NVS) opens the door to a potential break up, but argues there are benefits to keeping pharmaceuticals, vaccines and consumer goods together and there would be “no logic” in a split at this early time after the Novartis deal, the report added. Reference Link
14:57 EDTAAPLUSPTO sides with Apple, says certain claims of VirnetX 'unpatentable'
Subscribe for More Information
12:35 EDTGEGE not likely to gain unconditional approval for Alstom deal, Reuters reports
Subscribe for More Information
12:28 EDTGEGE launches cloud foundry ‘Industrial Dojo’
GE Software announced its ‘Industrial Dojo,’ in collaboration with the Cloud Foundry Foundation, to strengthen its efforts to solve the world’s biggest industrial challenges. The Cloud Foundry Dojo program allows software developers to immerse themselves in open source projects to quickly learn the inner workings of the core technology and the unique agile development environment, as well as recommended methodologies for contributing code. GE also announced it will work with the Cloud Foundry community to develop and contribute open source code to the Cloud Foundry Foundation that will route all industrial messaging protocols. By opening this Industrial Dojo, GE Software is enabling developers to better learn industrial intricacies by pairing with experienced developers, thereby greatly reducing the time-to-productivity for those new to a project. Through this program, GE is bolstering its commitment to open source development and Cloud Foundry, and ultimately promoting the next wave of industrial innovation. Also announced, GE will drive, in collaboration with Pivotal, creation of a “TCP Router” to direct non-HTTP protocols and better equip Cloud Foundry to connect industrial machines with IT networks. By donating this innovation to the open source community, GE will enable Cloud Foundry to be used in a variety of industrial applications and use cases.
12:17 EDTAAPLApple mulls expansion of key Irish plant, Independent. ie says
Subscribe for More Information
11:37 EDTAAPLApple expanding renewable energy projects in China
Subscribe for More Information
11:24 EDTAAPLUBS says Apple Watch could become 'must-have' device, but not yet
Subscribe for More Information
10:21 EDTGEGE says EU suspends review on Alstom deal, sees probe resuming, Reuters reports
General Electric (GE) said the investigation of its takeover bid for Alstom's (ALSMY) power equipment business was suspended last month by EU antitrust regulators, Reuters reports. GE says the probe was halted on April 24 to give the regulators time to review additional information, and believes the review will restart this week. Reference Link
09:56 EDTAAPLIDC: Apple leads smartphone vendors in China during Q1
IDC’s latest Mobile Phone Tracker shows the China smartphone market contracted by 4% year-on-year with 98.8M units shipped in the first quarter of 2015. This is the first time in six years that the China smartphone market declined YoY as the market continues to mature. On a QoQ basis, the market contracted 8% on the back of a large inventory buildup at the end of last year. The study said Apple (AAPL) was the top smartphone vendor in China in the first quarter, with consumers still having a strong appetite for the larger screens on the iPhone 6 and iPhone 6 Plus. Xiaomi slipped to the second position as it faced strong competition from other vendors in the low to mid-range segment of the market, while Huawei maintained third position as it saw a good uptake in the mid-range segment. Samsung (SSNLF) and Lenovo (LNVGY) both led the market at least once last year, but rankings have since changed quickly, highlighting the volatility of consumers' brand preference in China. Reference Link
09:37 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:41 EDTAAPLApple Watch may become 'must have' as interface to internet, says UBS
Subscribe for More Information
06:44 EDTAAPLFiat Chrysler CEO met with Apple, Tesla CEOs, Reuters says
During a trip to California, Fiat Chrysler (FCAU) CEO Sergio Marchionne met with Apple (AAPL) CEO, Tim Cook, and Tesla (TSLA) CEO Elon Musk, reports Reuters, citing Marchionne. Marchionne also vowed that the company would make a stronger attempt in the luxury SUV market, Reuters adds. Reference Link
05:58 EDTGSKUNC, GlaxoSmithKline create dedicated HIV Cure center
Subscribe for More Information
05:05 EDTAAPLApple announces environmental initiatives in China
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use